Éric Jourdan
Impact in
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 27
- Myeloproliferative Neoplasms: Diagnosis and Treatment 20
- Chronic Lymphocytic Leukemia Research 6
- Hematology 23
- Chronic Myeloid Leukemia Treatments 14
- Multiple Myeloma Research and Treatments 7
- Acute Myeloid Leukemia Research 7
- Co-authors
- Mauro Picardo (1 shared paper)Christos C. Zouboulis (1 shared paper)Catherine Grosset (8 shared papers)A. Ravel (8 shared papers)Éric Peyrin (8 shared papers)Annick Villet (8 shared papers)Claire Harrison (15 shared papers)Alessandro M. Vannucchi (15 shared papers)
- Journals
- Blood (12 papers)Journal of Clinical Oncology (7 papers)Journal of the European Academy of Dermatology and Venereology (3 papers)HemaSphere (3 papers)American Journal of Hematology (2 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Éric Jourdan
57 papers receiving 2.1k citations
Éric Jourdan's Hit Papers
Peers
Comparison fields: 5 of 104
- Genetics 802
- Hematology 601
- Dermatology 269
- Rheumatology 260
- Molecular Biology 835
Countries citing papers authored by Éric Jourdan
This map shows the geographic impact of Éric Jourdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Jourdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Jourdan more than expected).
Fields of papers citing papers by Éric Jourdan
This network shows the impact of papers produced by Éric Jourdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Jourdan. The network helps show where Éric Jourdan may publish in the future.
Co-authors
The 25 scholars most cited alongside Éric Jourdan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis Hit paper breakdown → | 2015 | 348 |
| 2 | 2017 | 229 | |
| 3 | 2013 | 214 | |
| 4 | 2003 | 163 | |
| 5 | 2003 | 162 | |
| 6 | 2007 | 116 | |
| 7 | 2020 | 107 | |
| 8 | 2004 | 101 | |
| 9 | 2009 | 89 | |
| 10 | 2018 | 48 | |
| 11 | 2001 | 47 | |
| 12 | 2021 | 40 | |
| 13 | 2006 | 34 | |
| 14 | 1995 | 32 | |
| 15 | 2002 | 28 | |
| 16 | 2003 | 28 | |
| 17 | 2011 | 28 | |
| 18 | 2013 | 27 | |
| 19 | 2015 | 27 | |
| 20 | 2002 | 26 |
About Éric Jourdan
Éric Jourdan is a scholar working on Genetics, Hematology, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 60 papers that have together received 2.1k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (20 papers), Chronic Myeloid Leukemia Treatments (14 papers), Lymphoma Diagnosis and Treatment (8 papers), Multiple Myeloma Research and Treatments (7 papers), Acute Myeloid Leukemia Research (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Analytical Chemistry and Chromatography (5 papers) and Eosinophilic Disorders and Syndromes (5 papers). The work is most often cited by research in Genetics (802 citations), Hematology (601 citations), Dermatology (269 citations), Rheumatology (260 citations) and Molecular Biology (835 citations). Éric Jourdan has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Mauro Picardo, Christos C. Zouboulis, Catherine Grosset, A. Ravel, Éric Peyrin, Annick Villet, Claire Harrison, Alessandro M. Vannucchi, Ruben A. Mesa and Francesco Passamonti. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of the European Academy of Dermatology and Venereology, HemaSphere and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.